Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Late Onset of Primary Hemophagocytic Lymphohistiocytosis (HLH) with a Novel Constellation of Compound Heterozygosity Involving Two Missense Variants in the PRF1 Gene.
Stadermann A, Haar M, Riecke A, Mayer T, Neumann C, Bauer A, Schulz A, Nagarathinam K, Gebauer N, Böhm S, Groß M, Grunert M, Müller M, Witte H. Stadermann A, et al. Among authors: riecke a. Int J Mol Sci. 2024 Feb 27;25(5):2762. doi: 10.3390/ijms25052762. Int J Mol Sci. 2024. PMID: 38474010 Free PMC article. Review.
Addition of isatuximab to lenalidomide, bortezomib, and dexamethasone as induction therapy for newly diagnosed, transplantation-eligible patients with multiple myeloma (GMMG-HD7): part 1 of an open-label, multicentre, randomised, active-controlled, phase 3 trial.
Goldschmidt H, Mai EK, Bertsch U, Fenk R, Nievergall E, Tichy D, Besemer B, Dürig J, Schroers R, von Metzler I, Hänel M, Mann C, Asemissen AM, Heilmeier B, Weinhold N, Huhn S, Kriegsmann K, Luntz SP, Holderried TAW, Trautmann-Grill K, Gezer D, Klaiber-Hakimi M, Müller M, Khandanpour C, Knauf W, Scheid C, Munder M, Geer T, Riesenberg H, Thomalla J, Hoffmann M, Raab MS, Salwender HJ, Weisel KC; German-Speaking Myeloma Multicenter Group (GMMG) HD7 investigators. Goldschmidt H, et al. Lancet Haematol. 2022 Nov;9(11):e810-e821. doi: 10.1016/S2352-3026(22)00263-0. Lancet Haematol. 2022. PMID: 36328040 Clinical Trial.
Prognostic impact of nutritional and inflammation-based risk scores in follicular lymphoma in the era of anti-CD20 targeted treatment strategies.
Gebauer N, Mengler B, Kopelke S, Frydrychowicz A, Fürschke A, Hackenbroch C, Bauer A, Riecke A, von Bubnoff N, Fetscher S, Witte HM. Gebauer N, et al. Among authors: riecke a. J Cancer Res Clin Oncol. 2022 Jul;148(7):1789-1801. doi: 10.1007/s00432-021-03758-5. Epub 2021 Aug 20. J Cancer Res Clin Oncol. 2022. PMID: 34415426 Free PMC article.
The Glasgow Prognostic Score at Diagnosis Is a Predictor of Clinical Outcome in Patients with Multiple Myeloma Undergoing Autologous Haematopoietic Stem Cell Transplantation.
Witte HM, Bonorden B, Riecke A, Biersack H, Steinestel K, Merz H, Feller AC, Bernard V, Fetscher S, von Bubnoff N, Gebauer N. Witte HM, et al. Among authors: riecke a. Cancers (Basel). 2020 Apr 9;12(4):921. doi: 10.3390/cancers12040921. Cancers (Basel). 2020. PMID: 32283706 Free PMC article.
Prognostic Impact of PD-L1 Expression in Malignant Salivary Gland Tumors as Assessed by Established Scoring Criteria: Tumor Proportion Score (TPS), Combined Positivity Score (CPS), and Immune Cell (IC) Infiltrate.
Witte HM, Gebauer N, Lappöhn D, Umathum VG, Riecke A, Arndt A, Steinestel K. Witte HM, et al. Among authors: riecke a. Cancers (Basel). 2020 Apr 3;12(4):873. doi: 10.3390/cancers12040873. Cancers (Basel). 2020. PMID: 32260165 Free PMC article.
26 results